UNSPSC 51393800: Combination sympathomimetics (adrenergics)

This classification denotes combination drugs and preparations mimic the effects of stimulating postganglionic adrenergic sympathetic nerves, such as drugs that stimulate adrenergic receptors or which act indirectly by provoking the release of adrenergic transmitters, hence the term sympathomimetics and adrenergics. Typical combination sympathomimetic or adrenergic constituients are dextrose, dopamine, isoproterenol, and sodium chloride.

UNSPSC 51393800 Combination sympathomimetics (adrenergics), a Class code, shows recent state and local procurement activity focused on naloxone and drug deactivation systems for community health and emergency response initiatives. State and local issuing bodies buying under this code include county health departments and state health and human services agencies procuring naloxone supplies and related pharmaceutical products to support public health missions, particularly opioid-response programs and pharmacy benefit management infrastructure.

Recent activity spans Florida and Texas. Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. The Texas Health and Human Services Commission issued an RFI (HHS0017013) posted in April 2026 to gather vendor information on implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would establish direct relationships between the state's pharmacy benefit program and pharmaceutical manufacturers to improve prescription fulfillment and cost management. Both solicitations emphasize vendor compliance with federal and state requirements, including drug-free workplace certification and E-Verify compliance in the Seminole County case, and direct contracting flexibility with negotiated net pricing in the Texas RFI. The source shows limited recent activity under this code; the two opportunities reflect disparate procurement objectives—one focused on emergency-response pharmaceutical supplies and the other on pharmacy benefit program infrastructure—suggesting the code may not be the primary classification vehicle for state and local sympathomimetic purchasing.